MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$786.723M
(-34.00%↓ Y/Y)
Net loss
-$784.955M
(-33.15%↓ Y/Y)
Unrealized (loss) gain on
available-for-sale securities, net
-$0.99M
(-145.98%↓ Y/Y)
Foreign currency
translation adjustments
-$0.778M
(-405.10%↓ Y/Y)
Interest and other
income, net
$48.42M
(-6.04%↓ Y/Y)
License And Milestone
Revenues
$79.353M
Collaboration Revenues
$8.686M
Change in fair value of
derivative liabilities
$4.2M
(223.08%↑ Y/Y)
Operating loss
-$612.258M
(-14.17%↓ Y/Y)
Debt conversion
expense
$121.249M
Non-cash interest
expense on liabilities...
$58.289M
(19.42%↑ Y/Y)
Total revenues
$88.039M
(486.93%↑ Y/Y)
Interest expense
$45.579M
(20.90%↑ Y/Y)
Change in fair value of
liabilities related to rpi...
-$0.2M
(98.98%↑ Y/Y)
Total operating
expenses
$700.297M
(26.24%↑ Y/Y)
Research and development
$416.026M
(22.57%↑ Y/Y)
General and
administrative
$284.271M
(32.03%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
CYTOKINETICS INC (CYTK)
CYTOKINETICS INC (CYTK)